Not only is gonorrhoea becoming increasingly common, but rising antibiotic resistance is making the once easily curable infection increasingly difficult to treat, reports Katharine Lang Drug resistant ...
Debio1453 is a first-in-class antibiotic candidate that targets an enzyme that’s essential for the growth of Neisseria ...
The GARDP Foundation (known as GARDP) and the privately-owned, global biopharmaceutical company Debiopharm today announced ...
Neisseria gonorrhoeae bacteria, as seen in this illustration, consist of a pair of cells, called diplococci, and have hair-like pili on their surfaces. They can cause the sexually transmitted ...
Gonorrhea is a very common sexually transmitted disease (STD) caused by a bacterium/superbug called Neisseria gonorrhoeae. It is spread during sexual intercourse - vaginal, oral, and anal. Most often, ...
What’s worse than being told that you have gonorrhea? How about being told that you are the first case in the U.S. of gonorrhea that has either no response or reduced response to five different ...
Their specificity for the host is partly achieved by specific host adhesion mechanisms. As adhesins are required for the first step of colonization, they also constitute key virulence factors and have ...
Please provide your email address to receive an email when new articles are posted on . Massachusetts health officials detected a novel strain of gonorrhea with reduced susceptibility or resistance to ...
Researchers at the University of Maryland figured out why some Neisseria gonorrhoeae infections become invasive, while others don’t. More invasive strains cause the epithelial layer of the endocervix ...
GENEVA & LAUSANNE, Switzerland--(BUSINESS WIRE)--The Global Antibiotic Research & Development Partnership (GARDP) and the Swiss-based global biopharmaceutical company Debiopharm have signed a ...
The GARDP Foundation and Debiopharm have entered a collaboration and license agreement to pursue the development of a novel, first-in-class antibiotic targeting Neisseria gonorrhoeae.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback